Acorda Therapeutics Incorporated (ACOR) Stock Quote
Get the latest ACOR - Acorda Therapeutics Incorporated stock market performance data and financial news.
Acorda Therapeutics Incorporated (ACOR) Community Sentiment ...
Get the latest ACOR - Acorda Therapeutics Incorporated together with stock market performance data and financial news.
Jim Cramer's Take on Acorda Therapeutics Incorporated
Read Jim Cramer's take on Acorda Therapeutics Incorporated (ACOR) and get his latest thoughts on the company?s performance and outlook
Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
RealMoney.com Print Day's Entries - Columnist Conversation
... Daniel Loeb of Third Point wrote a letter to the CEO of Acorda Therapeutics (ACOR),
demanding the company be sold. ... ACOR was a $2 stock, now it's $22. ...
FDA Won't Review Acorda's MS Drug
Acorda Therapeutics said the Food and Drug Administration asked it to reformat some fampridine data and requested further supporting information.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10479750/1/fda-wont-review-acordas-ms-drug.html
Seattle Genetics Halts Lymphoma Drug Study: BioBuzz
Drug deemed futile by independent data monitors, other trials continue. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10606960/1/seattle-genetics-halts-lymphoma-drug-study-biobuzz.html
Options Recap: Bullish on Acorda, Lloyds
Options action turned bullish in Acorda Therapeutics as traders bet the drugmaker would keep rallying this week.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10516706/1/options-recap-bullish-on-acorda-lloyds.html
FDA Panel Votes 'Yes' on Acorda Drug Efficacy: BioBuzz
FDA advisory panel reviewing Acorda's multiple sclerosis drug.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10611519/1/fda-panel-votes-yes-on-acorda-drug-efficacy-biobuzz.html
Sequenom Fallout Hits Hedge Funds
Investors are selling biotech stocks owned by two hedge funds that took highly concentrated positions in Sequenom on fears that they may be forced to liquidate their other holdings.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10494530/1/sequenom-fallout-hits-hedge-funds.html
Connect with TheStreet